Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Biocon Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

30 Apr 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Biocon Ltd (BIOCON-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

20 May 2016 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Biocon Limited

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

15 May 2016 Wright Reports 55 $75.00

Biocon Limited (BIOCON) - Financial and Strategic SWOT Analysis Review

Biocon Limited (BIOCON) - Financial and Strategic SWOT Analysis Review Summary Biocon Limited (Biocon) is a global biopharmac...

06 May 2016 GlobalData 97 $300.00

Thomson Reuters Stock Report - Biocon Ltd (BIOCON-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

06 May 2016 Thomson Reuters Stock Report 11 $25.00

Company Snapshot - Biocon Limited

A director at Biocon Limited sold 4,000 shares at 0.000INR and the significance rating of the trade was 52/100. Is that info...

05 May 2016 Directors Deals Ltd. 1 $12.00

Spark Capital: 4QFY16 outlook review of Biocon (Rating: BUY, TP: Rs. 650)

4QFY16 outlook review of Biocon (Rating: BUY, TP: Rs. 650) How does our one year outlook change? We maintain ‘BUY’ rating...

29 Apr 2016 Spark Capital Advisors(India) Private Limited 6 $46.00

MOSL: Biocon 4QFY16 (Sell)-Mixed results-Development on Biosimilars portfolio is key.

BIOCON 4QFY16: Mixed results; Development on Biosimilars portfolio is key (BIOS IN, Mkt Cap USD1.7b, CMP INR571, TP INR490, ...

28 Apr 2016 Motilal Oswal Securities Ltd. 12 $115.00

Biocon (BIOS)_Q4FY16 Result Update

Biocon (BIOS) CRAMS drives earnings for the quarter Biocon (BIOS) Q4FY16 sales were better-than-estimates, while adjusted...

28 Apr 2016 IndiaNivesh Securities Pvt Ltd 6 $58.00

Biocon Ltd. (BIOS) - Qtr. Update - Dated - April 27, 2016

Biocon (Bloomberg: BIOS IN, BUY, TP – Rs 680, 19% upside from CMP of Rs 571) Biocon posted higher growth of 11% YoY (vs. 3...

28 Apr 2016 Axis Capital Limited 6 $58.00